Sulfalene

Chemical used to treat pulmonary issues
  • J01ED02 (WHO) QJ01EQ19 (WHO)
Pharmacokinetic dataProtein binding60 to 80%[1]Elimination half-life60 to 65 hours[1]ExcretionUrinary[1]Identifiers
  • 4-Amino-N-(3-methoxypyrazinyl)benzenesulfonamide
CAS Number
  • 152-47-6 checkY
PubChem CID
  • 9047
DrugBank
  • DB00664 checkY
ChemSpider
  • 8695 checkY
UNII
  • T6BL4ZC15G
KEGG
  • D01216 checkY
CompTox Dashboard (EPA)
  • DTXSID2046179 Edit this at Wikidata
ECHA InfoCard100.005.278 Edit this at WikidataChemical and physical dataFormulaC11H12N4O3SMolar mass280.30 g·mol−13D model (JSmol)
  • Interactive image
  • O=S(=O)(Nc1nccnc1OC)c2ccc(N)cc2
InChI
  • InChI=1S/C11H12N4O3S/c1-18-11-10(13-6-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15) checkY
  • Key:KXRZBTAEDBELFD-UHFFFAOYSA-N checkY
  (verify)

Sulfalene (INN, USAN) or sulfametopyrazine (BAN) is a long-acting sulfonamide antibacterial used for the treatment of chronic bronchitis, urinary tract infections and malaria.[2][3] As of 2014 there were only two countries in which it is currently still marketed: Thailand and Ireland.[3]

It was discovered by researchers at Farmitalia and first published in 1960 and was marketed as Kelfizina.[4][5]

See also

References

  1. ^ a b c d "Sulfalene". MIMS Drug Information System. Retrieved 26 August 2011.
  2. ^ DrugBank DB00664
  3. ^ a b Brayfield A, ed. (9 May 2013). "Sulfametopyrazine". Martindale: The Complete Drug Reference. Pharmaceutical Press. Retrieved 28 March 2014.
  4. ^ Baruffa G (1966). "Clinical trials in Plasmodium falciparum malaria with a long-acting sulphonamide". Transactions of the Royal Society of Tropical Medicine and Hygiene. 60 (2): 222–4. doi:10.1016/0035-9203(66)90030-7. PMID 5332105.
  5. ^ Per prior citation, the first publication: Camerino B, Palamidessi G (1960). "Derivati della parazina II. Sulfonamdopir". Gazz Chim Ital (in Italian). 90: 1802–1815.
  • v
  • t
  • e
Antifolates
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
DHFR inhibitor
Sulfonamides
(DHPS inhibitor)
Short-acting
Intermediate-acting
Long-acting
Other/ungrouped
Combinations
Other DHPS inhibitors
Quinolones
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
1st generation
Fluoroquinolones
2nd generation
3rd generation
4th generation
Veterinary
Newer non-fluorinated
Related (DG)
Anaerobic DNA
inhibitors
Nitroimidazole derivatives
Nitrofuran derivatives
RNA synthesis
Rifamycins/
RNA polymerase
Lipiarmycins
Stub icon

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e